Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assess efficacy, safety, adherence and persistence of inclisiran, and clinician's behavior on LLT in very high CV risk patients with atherosclerotic CV disease and/or familial hypercholesterolemia (FH)

Next Previous
Search
Trial Profile

Assess efficacy, safety, adherence and persistence of inclisiran, and clinician's behavior on LLT in very high CV risk patients with atherosclerotic CV disease and/or familial hypercholesterolemia (FH)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Oct 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Inclisiran (Primary) ; Ezetimibe; HMG-CoA reductase inhibitors
  • Indications Hypercholesterolaemia; Hyperlipidaemia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Cholinet

    • Most Recent Events

    • 02 Sep 2024 Results presented at the ESC Congress 2024 - Annual Congress of the European Society of Cardiology
    • 09 Oct 2023 New trial record
    • 28 Aug 2023 Results assessing the efficacy, safety, adherence and persistence, as well characteristics of very high risk patients with atherosclerotic CV disease (ASCVD) and/or familial hypercholesterolemia (FH) receiving inclisiran, presented at the ESC Congress 2023 - Annual Congress of the European Society of Cardiology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top